Investegate |Excision BioTherapeutics Announcements | Excisi

Investegate announcements from Excision BioTherapeutics, Excision BioTherapeutics Initiates Phase 1/2 Trial Evaluating EBT-101 as a Potential Cure for HIV

Related Keywords

California , United States , San Francisco , Robert Flamm , Lisa Danzig , Daniel Dornbusch , John Fraunces , Rachelm Presti , Excision Biotherapeutics Inc , Loreda Holdings , Burns Mcclellan Inc , Temple University , Potential Cure , Chief Executive Officer , Chief Medical Officer , Associate Professor , Washington University School , Principal Investigator , Greatpoint Ventures , Norwest Venture Partners , Adjuvant Capital , Cota Capital , Celesta Capital , Indusage Partners , Olive Tree , Anzu Partners , Silverridge Venture Partners , Oakhouse Ventures , Investegate Announcements , Investegate Company Announcements , Excision Biotherapeutics , Lobenewswire , Lobenewswire And Globenewswire , Nw ,